DOE PAGES title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: The triphenylmethane dye brilliant blue G is only moderately effective at inhibiting amyloid formation by human amylin or at disaggregating amylin amyloid fibrils, but interferes with amyloid assays; Implications for inhibitor design

Abstract

The development of inhibitors of islet amyloid formation is important as pancreatic amyloid deposition contributes to type-2 diabetes and islet transplant failure. The Alzheimer’s Aβ peptide and human amylin (h-amylin), the polypeptide responsible for amyloid formation in type-2 diabetes, share common physio-chemical features and some inhibitors of Aβ also inhibit amyloid formation by h-amylin and vice versa. Thus, a popular and potentially useful strategy to find lead compounds for anti-amylin amyloid agents is to examine compounds that have effects on Aβ amyloid formation. The triphenylmethane dye, brilliant blue G (BBG, Sodium;3-[[4-[(E)-[4-(4-ethoxyanilino)phenyl]-[4-[ethyl-[(3-sulfonatophenyl)methyl]azaniumylidene]-2-methylcyclohexa-2,5-dien-1-ylidene]methyl]-N-ethyl-3-methylanilino]methyl]benzenesulfonate) has been shown to modulate Aβ amyloid formation and inhibit Aβ induced toxicity. However, the effects of BBG on h-amylin have not been examined, although other triphenylmethane derivatives inhibit h-amylin amyloid formation. The compound has only a modest impact on h-amylin amyloid formation unless it is added in significant excess. BBG also remodels preformed h-amylin amyloid fibrils if added in excess, however BBG has no significant effect on h-amylin induced toxicity towards cultured β-cells or cultured CHO-T cells except at high concentrations. BBG is shown to interfere with standard thioflavin-T assays of h-amylin amyloid formation and disaggregation, highlighting the difficulty of interpreting such experiments in the absence of othermore » measurements. BBG also interferes with ANS based assays of h-amylin amyloid formation. The work highlights the differences between inhibition of Aβ and h-amylin amyloid formation, illustrates the limitation of using Aβ inhibitors as leads for h-amylin amyloid inhibitors, and reinforces the difficulties in interpreting dye binding assays of amyloid formation.« less

Authors:
; ; ; ; ORCiD logo;
Publication Date:
Research Org.:
Brookhaven National Laboratory (BNL), Upton, NY (United States)
Sponsoring Org.:
USDOE Office of Science (SC), Basic Energy Sciences (BES)
OSTI Identifier:
1556818
Alternate Identifier(s):
OSTI ID: 1689562
Report Number(s):
BNL-220180-2020-JACI
Journal ID: ISSN 1932-6203; 10.1371/journal.pone.0219130
Grant/Contract Number:  
SC0012704
Resource Type:
Published Article
Journal Name:
PLoS ONE
Additional Journal Information:
Journal Name: PLoS ONE Journal Volume: 14 Journal Issue: 8; Journal ID: ISSN 1932-6203
Publisher:
Public Library of Science (PLoS)
Country of Publication:
United States
Language:
English
Subject:
99 GENERAL AND MISCELLANEOUS

Citation Formats

Akter, Rehana, Zhyvoloup, Alexander, Zheng, Bingqian, Bhatia, Surita R., Raleigh, Daniel P., and Ginsberg, ed., Stephen D. The triphenylmethane dye brilliant blue G is only moderately effective at inhibiting amyloid formation by human amylin or at disaggregating amylin amyloid fibrils, but interferes with amyloid assays; Implications for inhibitor design. United States: N. p., 2019. Web. doi:10.1371/journal.pone.0219130.
Akter, Rehana, Zhyvoloup, Alexander, Zheng, Bingqian, Bhatia, Surita R., Raleigh, Daniel P., & Ginsberg, ed., Stephen D. The triphenylmethane dye brilliant blue G is only moderately effective at inhibiting amyloid formation by human amylin or at disaggregating amylin amyloid fibrils, but interferes with amyloid assays; Implications for inhibitor design. United States. https://doi.org/10.1371/journal.pone.0219130
Akter, Rehana, Zhyvoloup, Alexander, Zheng, Bingqian, Bhatia, Surita R., Raleigh, Daniel P., and Ginsberg, ed., Stephen D. Mon . "The triphenylmethane dye brilliant blue G is only moderately effective at inhibiting amyloid formation by human amylin or at disaggregating amylin amyloid fibrils, but interferes with amyloid assays; Implications for inhibitor design". United States. https://doi.org/10.1371/journal.pone.0219130.
@article{osti_1556818,
title = {The triphenylmethane dye brilliant blue G is only moderately effective at inhibiting amyloid formation by human amylin or at disaggregating amylin amyloid fibrils, but interferes with amyloid assays; Implications for inhibitor design},
author = {Akter, Rehana and Zhyvoloup, Alexander and Zheng, Bingqian and Bhatia, Surita R. and Raleigh, Daniel P. and Ginsberg, ed., Stephen D.},
abstractNote = {The development of inhibitors of islet amyloid formation is important as pancreatic amyloid deposition contributes to type-2 diabetes and islet transplant failure. The Alzheimer’s Aβ peptide and human amylin (h-amylin), the polypeptide responsible for amyloid formation in type-2 diabetes, share common physio-chemical features and some inhibitors of Aβ also inhibit amyloid formation by h-amylin and vice versa. Thus, a popular and potentially useful strategy to find lead compounds for anti-amylin amyloid agents is to examine compounds that have effects on Aβ amyloid formation. The triphenylmethane dye, brilliant blue G (BBG, Sodium;3-[[4-[(E)-[4-(4-ethoxyanilino)phenyl]-[4-[ethyl-[(3-sulfonatophenyl)methyl]azaniumylidene]-2-methylcyclohexa-2,5-dien-1-ylidene]methyl]-N-ethyl-3-methylanilino]methyl]benzenesulfonate) has been shown to modulate Aβ amyloid formation and inhibit Aβ induced toxicity. However, the effects of BBG on h-amylin have not been examined, although other triphenylmethane derivatives inhibit h-amylin amyloid formation. The compound has only a modest impact on h-amylin amyloid formation unless it is added in significant excess. BBG also remodels preformed h-amylin amyloid fibrils if added in excess, however BBG has no significant effect on h-amylin induced toxicity towards cultured β-cells or cultured CHO-T cells except at high concentrations. BBG is shown to interfere with standard thioflavin-T assays of h-amylin amyloid formation and disaggregation, highlighting the difficulty of interpreting such experiments in the absence of other measurements. BBG also interferes with ANS based assays of h-amylin amyloid formation. The work highlights the differences between inhibition of Aβ and h-amylin amyloid formation, illustrates the limitation of using Aβ inhibitors as leads for h-amylin amyloid inhibitors, and reinforces the difficulties in interpreting dye binding assays of amyloid formation.},
doi = {10.1371/journal.pone.0219130},
journal = {PLoS ONE},
number = 8,
volume = 14,
place = {United States},
year = {Mon Aug 12 00:00:00 EDT 2019},
month = {Mon Aug 12 00:00:00 EDT 2019}
}

Journal Article:
Free Publicly Available Full Text
Publisher's Version of Record
https://doi.org/10.1371/journal.pone.0219130

Citation Metrics:
Cited by: 4 works
Citation information provided by
Web of Science

Save / Share:

Works referenced in this record:

Diabetes Mellitus and Dementia
journal, March 2014


The Amyloid State of Proteins in Human Diseases
journal, March 2012


Selectively N-Methylated Soluble IAPP Mimics as Potent IAPP Receptor Agonists and Nanomolar Inhibitors of Cytotoxic Self-Assembly of Both IAPP and Aβ40
journal, August 2013

  • Yan, Li-Mei; Velkova, Aleksandra; Tatarek-Nossol, Marianna
  • Angewandte Chemie International Edition, Vol. 52, Issue 39
  • DOI: 10.1002/anie.201302840

Insight into Clustering in Poly(ethylene oxide) Solutions
journal, September 2004

  • Hammouda, Boualem; Ho, Derek L.; Kline, Steve
  • Macromolecules, Vol. 37, Issue 18
  • DOI: 10.1021/ma049623d

EGCG remodels mature α-synuclein and amyloid-β fibrils and reduces cellular toxicity
journal, April 2010

  • Bieschke, Jan; Russ, Jenny; Friedrich, Ralf P.
  • Proceedings of the National Academy of Sciences, Vol. 107, Issue 17
  • DOI: 10.1073/pnas.0910723107

Islet Amyloid Polypeptide, Islet Amyloid, and Diabetes Mellitus
journal, July 2011

  • Westermark, Per; Andersson, Arne; Westermark, Gunilla T.
  • Physiological Reviews, Vol. 91, Issue 3
  • DOI: 10.1152/physrev.00042.2009

A Safe, Blood-Brain Barrier Permeable Triphenylmethane Dye Inhibits Amyloid-β Neurotoxicity by Generating Nontoxic Aggregates
journal, September 2011

  • Wong, H. Edward; Qi, Wei; Choi, Hyung-Min
  • ACS Chemical Neuroscience, Vol. 2, Issue 11
  • DOI: 10.1021/cn200056g

Small molecule inhibits α-synuclein aggregation, disrupts amyloid fibrils, and prevents degeneration of dopaminergic neurons
journal, September 2018

  • Pujols, Jordi; Peña-Díaz, Samuel; Lázaro, Diana F.
  • Proceedings of the National Academy of Sciences, Vol. 115, Issue 41
  • DOI: 10.1073/pnas.1804198115

RAGE binds preamyloid IAPP intermediates and mediates pancreatic β cell proteotoxicity
journal, January 2018

  • Abedini, Andisheh; Cao, Ping; Plesner, Annette
  • Journal of Clinical Investigation, Vol. 128, Issue 2
  • DOI: 10.1172/JCI85210

Molecular basis of the inhibition and disaggregation of thermally-induced amyloid fibrils of human serum albumin by an anti-Parkinson's drug, benserazide hydrochloride
journal, March 2019

  • Chandel, Tajalli Ilm; Masroor, Aiman; Siddiqi, Mohammad Khursheed
  • Journal of Molecular Liquids, Vol. 278
  • DOI: 10.1016/j.molliq.2018.12.127

Binding Modes of Thioflavin-T to the Single-Layer β-Sheet of the Peptide Self-Assembly Mimics
journal, December 2009

  • Wu, Chun; Biancalana, Matthew; Koide, Shohei
  • Journal of Molecular Biology, Vol. 394, Issue 4
  • DOI: 10.1016/j.jmb.2009.09.056

Using an in-vacuum CCD detector for simultaneous small- and wide-angle scattering at beamline X9
journal, January 2013


Widespread Amyloid Deposition in Transplanted Human Pancreatic Islets
journal, August 2008

  • Westermark, Gunilla T.; Westermark, Per; Berne, Christian
  • New England Journal of Medicine, Vol. 359, Issue 9
  • DOI: 10.1056/NEJMc0802893

Islet amyloid: From fundamental biophysics to mechanisms of cytotoxicity
journal, February 2013


Influence of methionine–ruthenium complex on the fibril formation of human islet amyloid polypeptide
journal, January 2019

  • Gong, Gehui; Xu, Jufei; Huang, Xiangyi
  • JBIC Journal of Biological Inorganic Chemistry, Vol. 24, Issue 2
  • DOI: 10.1007/s00775-019-01637-6

Site-Specific Fluorescence Polarization for Studying the Disaggregation of α-Synuclein Fibrils by Small Molecules
journal, November 2016


Amyloid fibrils in human insulinoma and islets of Langerhans of the diabetic cat are derived from a neuropeptide-like protein also present in normal islet cells.
journal, June 1987

  • Westermark, P.; Wernstedt, C.; Wilander, E.
  • Proceedings of the National Academy of Sciences, Vol. 84, Issue 11
  • DOI: 10.1073/pnas.84.11.3881

Fluorescence Quantum Yield of Thioflavin T in Rigid Isotropic Solution and Incorporated into the Amyloid Fibrils
journal, October 2010


Beta amyloid and hyperphosphorylated tau deposits in the pancreas in type 2 diabetes
journal, September 2010


Aggregation of islet amyloid polypeptide: from physical chemistry to cell biology
journal, February 2013

  • Cao, Ping; Abedini, Andisheh; Raleigh, Daniel P.
  • Current Opinion in Structural Biology, Vol. 23, Issue 1
  • DOI: 10.1016/j.sbi.2012.11.003

Is type 2 diabetes an amyloidosis and does it really matter (to patients)?
journal, March 2010


Metabolic stress, IAPP and islet amyloid
journal, August 2012


Seeding Specificity in Amyloid Growth Induced by Heterologous Fibrils
journal, January 2004

  • O'Nuallain, Brian; Williams, Angela D.; Westermark, Per
  • Journal of Biological Chemistry, Vol. 279, Issue 17
  • DOI: 10.1074/jbc.M311300200

Inhibition of Glycosaminoglycan-Mediated Amyloid Formation by Islet Amyloid Polypeptide and proIAPP Processing Intermediates
journal, February 2011


Morin hydrate inhibits amyloid formation by islet amyloid polypeptide and disaggregates amyloid fibers
journal, January 2012

  • Noor, Harris; Cao, Ping; Raleigh, Daniel P.
  • Protein Science, Vol. 21, Issue 3
  • DOI: 10.1002/pro.2023

Kinetic and Conformational Insights into Islet Amyloid Polypeptide Self-Assembly Using a Biarsenical Fluorogenic Probe
journal, January 2018


Mechanisms of islet amyloidosis toxicity in type 2 diabetes
journal, January 2013


Fluorescence microscopy with thioflavine-T in the diagnosis of amyloid
journal, October 1963

  • Hobbs, J. R.; Morgan, A. D.
  • The Journal of Pathology and Bacteriology, Vol. 86, Issue 2
  • DOI: 10.1002/path.1700860218

Characterizing the assembly behaviors of human amylin: a perspective derived from C-terminal variants
journal, January 2013

  • Chen, Mei-Sha; Zhao, De-Sheng; Yu, Ye-Ping
  • Chem. Commun., Vol. 49, Issue 18
  • DOI: 10.1039/C2CC33432A

Peptide Conformation and Supramolecular Organization in Amylin Fibrils:  Constraints from Solid-State NMR
journal, November 2007

  • Luca, Sorin; Yau, Wai-Ming; Leapman, Richard
  • Biochemistry, Vol. 46, Issue 47
  • DOI: 10.1021/bi701427q

Efficient Microwave-Assisted Synthesis of Human Islet Amyloid Polypeptide Designed to Facilitate the Specific Incorporation of Labeled Amino Acids
journal, November 2010

  • Marek, Peter; Woys, Ann Marie; Sutton, Kelvin
  • Organic Letters, Vol. 12, Issue 21
  • DOI: 10.1021/ol101981b

Islet amyloid deposition limits the viability of human islet grafts but not porcine islet grafts
journal, February 2010

  • Potter, K. J.; Abedini, A.; Marek, P.
  • Proceedings of the National Academy of Sciences, Vol. 107, Issue 9
  • DOI: 10.1073/pnas.0909024107

ANS Binding Reveals Common Features of Cytotoxic Amyloid Species
journal, June 2010

  • Bolognesi, Benedetta; Kumita, Janet R.; Barros, Teresa P.
  • ACS Chemical Biology, Vol. 5, Issue 8
  • DOI: 10.1021/cb1001203

Evidence of fibril-like β-sheet structures in a neurotoxic amyloid intermediate of Alzheimer's β-amyloid
journal, December 2007

  • Chimon, Sandra; Shaibat, Medhat A.; Jones, Christopher R.
  • Nature Structural & Molecular Biology, Vol. 14, Issue 12
  • DOI: 10.1038/nsmb1345

Identification of Hot Regions of the Aβ-IAPP Interaction Interface as High-Affinity Binding Sites in both Cross- and Self-Association
journal, March 2010

  • Andreetto, Erika; Yan, Li-Mei; Tatarek-Nossol, Marianna
  • Angewandte Chemie International Edition, Vol. 49, Issue 17
  • DOI: 10.1002/anie.200904902

Protein Misfolding, Functional Amyloid, and Human Disease
journal, June 2006


Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases
journal, April 2002

  • Bucciantini, Monica; Giannoni, Elisa; Chiti, Fabrizio
  • Nature, Vol. 416, Issue 6880
  • DOI: 10.1038/416507a

Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients.
journal, December 1987

  • Cooper, G. J.; Willis, A. C.; Clark, A.
  • Proceedings of the National Academy of Sciences, Vol. 84, Issue 23
  • DOI: 10.1073/pnas.84.23.8628

Molecular links between Alzheimer’s disease and diabetes mellitus
journal, October 2013


Different Fates of Alzheimer’s Disease Amyloid-β Fibrils Remodeled by Biocompatible Small Molecules
journal, December 2012

  • Irwin, Jacob A.; Wong, H. Edward; Kwon, Inchan
  • Biomacromolecules, Vol. 14, Issue 1
  • DOI: 10.1021/bm3016994